Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Law MR, Wald NJ, Morris JK, Jordan RE.

BMJ. 2003 Jun 28;326(7404):1427.

PMID:
12829555
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.

Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.

Law M, Wald N, Morris J.

Health Technol Assess. 2003;7(31):1-94. Review.

PMID:
14604498
[PubMed - indexed for MEDLINE]
Free Article
4.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
[PubMed - indexed for MEDLINE]
5.

First-line drugs for hypertension.

Wright JM, Musini VM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001841. doi: 10.1002/14651858.CD001841.pub2. Review.

PMID:
19588327
[PubMed - indexed for MEDLINE]
6.

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.

Heran BS, Wong MM, Heran IK, Wright JM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD003823. doi: 10.1002/14651858.CD003823.pub2. Review.

PMID:
18843651
[PubMed - indexed for MEDLINE]
7.

Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.

Chen JM, Heran BS, Perez MI, Wright JM.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007185. doi: 10.1002/14651858.CD007185.pub2. Review.

PMID:
20091622
[PubMed - indexed for MEDLINE]
8.

Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.

Heran BS, Chen JM, Wang JJ, Wright JM.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008167. doi: 10.1002/14651858.CD008167.pub3. Review.

PMID:
23152254
[PubMed - indexed for MEDLINE]
9.

Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.

Heran BS, Chen JM, Wang JJ, Wright JM.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD008167. doi: 10.1002/14651858.CD008167.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD008167.

PMID:
20091662
[PubMed - indexed for MEDLINE]
10.

Vasoactive drugs for acute stroke.

Blood pressure in Acute Stroke Collaboration (BASC).

Cochrane Database Syst Rev. 2000;(4):CD002839. Review. Update in: Cochrane Database Syst Rev. 2010;(7):CD002839.

PMID:
11034772
[PubMed - indexed for MEDLINE]
11.

Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.

Leenen FH.

Can J Cardiol. 2004 Aug;20 Suppl B:77B-82B. Review.

PMID:
15309209
[PubMed - indexed for MEDLINE]
12.

Using fixed-dose combination therapies to achieve blood pressure goals.

Chrysant SG.

Clin Drug Investig. 2008;28(11):713-34. Review.

PMID:
18840014
[PubMed - indexed for MEDLINE]
13.

Systematic review: antihypertensive drug therapy in black patients.

Brewster LM, van Montfrans GA, Kleijnen J.

Ann Intern Med. 2004 Oct 19;141(8):614-27. Review.

PMID:
15492341
[PubMed - indexed for MEDLINE]
14.

Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.

Heran BS, Wong MM, Heran IK, Wright JM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD003822. doi: 10.1002/14651858.CD003822.pub2. Review.

PMID:
18843650
[PubMed - indexed for MEDLINE]
15.

Goals of antihypertensive therapy.

McVeigh GE, Flack J, Grimm R.

Drugs. 1995 Feb;49(2):161-75. Review.

PMID:
7729325
[PubMed - indexed for MEDLINE]
16.

Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review.

Musini VM, Fortin PM, Bassett K, Wright JM.

J Hum Hypertens. 2009 Aug;23(8):495-502. doi: 10.1038/jhh.2008.162. Epub 2009 Jan 22. Review.

PMID:
19158826
[PubMed - indexed for MEDLINE]
17.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
18.

Angiotensin-converting enzyme inhibitors and stroke risk: benefit beyond blood pressure reduction?

Hilleman DE, Lucas BD Jr.

Pharmacotherapy. 2004 Aug;24(8):1064-76. Review.

PMID:
15338854
[PubMed - indexed for MEDLINE]
19.

Valsartan: more than a decade of experience.

Black HR, Bailey J, Zappe D, Samuel R.

Drugs. 2009;69(17):2393-414. doi: 10.2165/11319460-000000000-00000. Review.

PMID:
19911855
[PubMed - indexed for MEDLINE]
20.

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J, Poulter N, Russell G.

J Hum Hypertens. 1999 Sep;13(9):569-92. Review.

PMID:
10482967
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk